Sequelae of COVID-19 With Focus on Exercise Capacity & Underlying

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04714788` - A Mobile App to Improve Participation in Following-up Cohorts	N/A
Completed	`NCT04201470` - Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis	N/A
Completed	`NCT03680885` - Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness	Early Phase 1
Active, not recruiting	`NCT02471625` - Traumatic Brain Injury Feasibility Study (EPIC-011)	N/A

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT04714788 - A Mobile App to Improve Participation in Following-up Cohorts

N/A

Completed

NCT04201470 - Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis

N/A

Completed

NCT03680885 - Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness

Early Phase 1

Active, not recruiting

NCT02471625 - Traumatic Brain Injury Feasibility Study (EPIC-011)

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05118711
Study type	Observational
Source	University of Basel
Contact	Arno Schmidt-Trucksäss, Prof.
Phone	+41 61 207 47 40
Email	arno.schmidt-trucksaess@unibas.ch
Status	Recruiting
Phase
Start date	January 3, 2023
Completion date	March 2024

Sequelae of COVID-19 With Focus on Exercise Capacity and Underlying Mechanisms — COR-PHYS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms